Enterprise Therapeutics Ltd has published significant findings from its Phase 1 trial of ETD001, a novel inhaled epithelial sodium channel (ENaC) blocker aimed at treating cystic...
Simon Wade, a 44-year-old sales consultant from Devon, recently learned he has been living with cystic fibrosis (CF) since birth, a revelation that profoundly changed his...
